Product Information
IBUPROFEN PM 200-38 MG CAPLET is a generic product labeled by Cardinal Health, priced at $0.1313 per EA under NDC 70000015703. Its NADAC has been published 59 times since Jul 9, 2025.
FDA first approved this application on Dec 22, 2008.
Strength
38; 200 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000015703
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIPHENHYDRAMINE CITRATE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA079113FDA Approved
12/22/2008
On Market Since
11/23/2016
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN PM 200-38 MG CAPLET has been published 59 times since Jul 9, 2025, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1313 per EA |
|---|---|
| All-time high | $0.1313 (Aug 19, 2026) |
| All-time low | $0.1249 (Apr 22, 2026) |
| 52-week high | $0.1313 |
| 52-week low | $0.1249 |
| Median price | $0.1265 |
| Average price | $0.1267 |
| Largest weekly change | +1.8% (May 20, 2026) |
| Weeks tracked | 59 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN PM 200-38 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN PM 200-38 MG CAPLET, manufactured by Cardinal Health, is $0.1313 per EA (NDC 70000015703), effective Aug 19, 2026.
How has the price of IBUPROFEN PM 200-38 MG CAPLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN PM 200-38 MG CAPLET has risen 4.9%. It has been tracked across 59 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for IBUPROFEN PM 200-38 MG CAPLET?
Since Jul 9, 2025, the NADAC for IBUPROFEN PM 200-38 MG CAPLET has ranged from a low of $0.1249 (Apr 22, 2026) to a high of $0.1313 (Aug 19, 2026), with a median of $0.1265 per EA.
Are there cheaper alternatives to IBUPROFEN PM 200-38 MG CAPLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN PM CAPLET, is $0.1250 per EA — about 5% below IBUPROFEN PM 200-38 MG CAPLET.
Who manufactures IBUPROFEN PM 200-38 MG CAPLET?
IBUPROFEN PM 200-38 MG CAPLET (NDC 70000015703) is labeled by Cardinal Health, and CMS classifies it as a generic product.